LungBlog

In response to the success of the studies, PhytoMedical’s collaborating scientists are now synthesizing and testing new derivatives of these anti-cancer agents. Further tests of the “DNA binding” anti-cancer agents are planned for human cancer cell lines specific to glioblastoma (tumors related to the brain) and small cell lung cancer, both of which are associated with a high mortality rate.

Contrary to previous studies, married patients with lung cancer do not have longer survival, according to analysis of an extensive Mayo Clinic database in the December issue of “The Oncologist.” However, the results suggest some other potentially important differences among patient subgroups — including the possibility that married patients receive a more aggressive approach to lung cancer treatment, write Dr. Aminah Jatoi and colleagues.

Hayley McDaid, Ph.D. assistant professor of medicine and of molecular pharmacology at Albert Einstein College of Medicine of Yeshiva University, has received a $100,000 grant from Joan’s Legacy: The Joan Scarangello Foundation to Conquer Lung Cancer for her research of lung cancer. The grant, which is being funded equally over two years by Joan’s Legacy and the LUNGevity Foundation, will support Dr. McDaid’s efforts to better understand mechanisms of specific lung cancer genotypes that contribute to the onset of lung cancer and how they can be targeted for therapy.

Bonnie J. Addario broke barriers by becoming one of the country’s top female oil company executives. Now, she is parlaying her professional prowess into running one of the country’s largest lung-cancer foundations.

 Lung cancer is the biggest killer of all cancers put together. The survival rate is poor – 80 per cent of patients die within the first year of diagnosis and only 7 per cent make it past five years. The earlier the diagnosis the better the chance of survival but it took doctors a year to diagnose my constituent.

There is no cancer from which someone has not been cured. That hopeful message is one that inspired Gallup resident Kathleen Houlihan when she battled lung cancer in 1999, and it’s a message she continues to share with other cancer patients today.Houlihan and recent cancer patient Michael Sullivan recently talked about their years as smokers, their diagnosis with lung cancer, their fight against the disease and their messages for both smokers and nonsmokers alike.

FASgen is pleased to report the publication of important research results for lung cancer treatment using FAS093, one of the Company’s proprietary compounds. In a long-standing cooperation with The Johns Hopkins Oncology Center, FASgen supported research into the selective inhibition of fatty acid synthase (FASi) at the Hopkins Oncology Center as a potential therapeutic agent against various forms of solid tumor cancers. In the recently reported study results, researchers at the Hopkins Oncology Center found that FAS093 significantly inhibited growth of several different xenograft tumors from human NSCLC cell lines. These extremely interesting results appear in the article, “Selective Inhibition of Fatty Acid Synthase for Lung Cancer Treatment,” Gabrielson et al, Clin Cancer Res 200l, 13(23) 7139-7145 (Dec. 1, 2007).

Bob Wettig took on the mission of warning students about the dangers of smoking after he was diagnosed several years ago with lung cancer.

“Our goal is to tell kids not to smoke and to quit if they already are,” said son Jeff Wettig of Richmond. “We had to spread the word, to tell people. We had to do it.”

Reid Hospital & Health Care Services is joining with the four Wettig children — in sponsoring the event.

A Plymouth company is developing technology that uses sensors and 3D mapping to try to detect lung cancer in its earliest, most treatable stages.

Even though lung cancer kills more New Yorkers each year than breast, colon, prostate, liver and kidney cancers and melanoma combined, there are no lung cancer survivors on the board. Research for early disease management, treatment and a cure for lung cancer remains a low priority. In fact, I don’t think it is even on Governor Spitzer’s radar screen.